Consequently, pharmacological inhibition of the STAT6 pathway emerges as a feasible strategy to regulate macrophage polarization, potentially impeding tumor progression and reducing chemoresistance in colorectal cancer. This evidence concerns the gene STAT6 and neoplasm.